Guoqing Xie

Key Laboratory Of Urinary Tumors
Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Docetaxel induced activation of GSDME pathway and pyroptosis enhance immune lethality in prostate cancer cells.

Docetaxel induced activation of GSDME pathway and pyroptosis enhance immune lethality in prostate cancer cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 21, 2025

LncPEDS1-AS promotes UTUC resistance to lipid peroxidation by regulating PEDS1 expression via DDX23.

LncPEDS1-AS promotes UTUC resistance to lipid peroxidation by regulating PEDS1 expression via DDX23.

Journal: Cell death & disease

Published: February 11, 2025

Vitamin A and its influence on tumour extracellular matrix.

Vitamin A and its influence on tumour extracellular matrix.

Journal: Discover oncology

Published: October 02, 2024

Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway.

Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway.

Journal: Cell death & disease

Published: April 16, 2024

Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators.

Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators.

Journal: Cell death & disease

Published: March 01, 2024

SYT4 binds to SNAP25 to facilitate exosomal secretion and prostate cancer enzalutamide resistance.

SYT4 binds to SNAP25 to facilitate exosomal secretion and prostate cancer enzalutamide resistance.

Journal: Cancer science

Published: January 12, 2024

8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer.

8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer.

Journal: Cell death discovery

Published: September 23, 2023

TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression.

TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 14, 2023

Transcriptomic insights into UTUC: role of inflammatory fibrosis and potential for personalized treatment.

Transcriptomic insights into UTUC: role of inflammatory fibrosis and potential for personalized treatment.

Journal: Journal of translational medicine

Published: September 14, 2023

Prediction for recurrent non-muscle invasive bladder cancer.

Prediction for recurrent non-muscle invasive bladder cancer.

Journal: Cancer biomarkers : section A of Disease markers

Published: September 04, 2023

Antibody-drug conjugates in urinary tumors: clinical application, challenge, and perspectives.

Antibody-drug conjugates in urinary tumors: clinical application, challenge, and perspectives.

Journal: Frontiers in oncology

Published: July 16, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026